Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents
- PMID: 8920699
- DOI: 10.1016/0264-410x(95)00195-7
Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate for use in protein-polysaccharide conjugate vaccines and immunological reagents
Abstract
Neonates have poor immune responses to type 2 T-cell independent antigens (TI-2), such as polysaccharides and immunization of human infants with these antigens does not induce protective levels of serum antibodies. Conjugating proteins to TI-2 antigens converts the immune response to one which is T-cell dependent. We used an organic cyanylating reagent, 1-cyano-4-dimethylaminopyridinium tetrafluroborate (CDAP), to activate polysaccharides, in water, and subsequently react them with hexanediamine, in preparation for coupling proteins to the polysaccharide. CDAP activation of polysaccharide is rapid (< 2 min) and efficient. CDAP can be used to activate polysaccharides of diverse chemical natures, including dextrans and pneumococcal types 6, 14, 19 and 23. The critical parameters in CDAP activation of polysaccharides were the reagent concentrations and the pH. Activation can be performed over a broad alkaline pH range, with an optimum of pH 9-10. Furthermore, proteins can be coupled to CDAP-activated polysaccharides without the use of a spacer. Direct conjugation of protein to CDAP-activated polysaccharides can be performed under mildly alkaline conditions (pH 7-9). These conditions allow CDAP to be used with alkaline-sensitive polysaccharides and proteins. Mice immunized with BSA-pneumococcal type 14 polysaccharides (Pn14) conjugates, prepared either by direct conjugation or via a spacer, had high anti-Pn14 and anti-BSA serum antibody IgG1 titers, whereas no IgG1 antibody was induced to the unconjugated components. The ease of use and mild activating conditions should prove of value in using CDAP to prepare conjugate vaccines, as well as other immunologically useful reagents.
Similar articles
-
Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides.Vaccine. 2000 Jan 18;18(13):1273-81. doi: 10.1016/s0264-410x(99)00370-9. Vaccine. 2000. PMID: 10649629
-
Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.Vaccine. 2011 Feb 24;29(10):1891-8. doi: 10.1016/j.vaccine.2010.12.134. Epub 2011 Jan 14. Vaccine. 2011. PMID: 21238568 Free PMC article.
-
Activation of Soluble Polysaccharides with 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) for Use in Protein-Polysaccharide Conjugate Vaccines and Immunological Reagents. III Optimization of CDAP Activation.Vaccines (Basel). 2020 Dec 18;8(4):777. doi: 10.3390/vaccines8040777. Vaccines (Basel). 2020. PMID: 33353255 Free PMC article.
-
Oligosaccharide-protein conjugates as vaccine candidates against bacteria.Adv Carbohydr Chem Biochem. 2000;56:153-99. doi: 10.1016/s0065-2318(01)56004-7. Adv Carbohydr Chem Biochem. 2000. PMID: 11039111 Review. No abstract available.
-
[A new vaccine concept: polysaccharide conjugate vaccines].Ann Pharm Fr. 1999 May;57(3):223-31. Ann Pharm Fr. 1999. PMID: 10427857 Review. French.
Cited by
-
A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faecium.J Biol Chem. 2015 Aug 7;290(32):19512-26. doi: 10.1074/jbc.M115.655852. Epub 2015 Jun 24. J Biol Chem. 2015. PMID: 26109072 Free PMC article.
-
Expressed Protein Ligation without Intein.J Am Chem Soc. 2020 Apr 15;142(15):7047-7054. doi: 10.1021/jacs.0c00252. Epub 2020 Apr 2. J Am Chem Soc. 2020. PMID: 32212692 Free PMC article.
-
Exploring the variables influencing the immune response of traditional and innovative glycoconjugate vaccines.Front Mol Biosci. 2023 May 16;10:1201693. doi: 10.3389/fmolb.2023.1201693. eCollection 2023. Front Mol Biosci. 2023. PMID: 37261327 Free PMC article. Review.
-
Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine.PLoS One. 2020 Dec 10;15(12):e0243909. doi: 10.1371/journal.pone.0243909. eCollection 2020. PLoS One. 2020. PMID: 33301525 Free PMC article.
-
Solution conformation and flexibility of capsular polysaccharides from Neisseria meningitidis and glycoconjugates with the tetanus toxoid protein.Sci Rep. 2016 Oct 26;6:35588. doi: 10.1038/srep35588. Sci Rep. 2016. PMID: 27782149 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources